Literature DB >> 12770663

Neuraxial opioid-induced pruritus: a review.

Szilvia Szarvas1, Dominic Harmon, Damian Murphy.   

Abstract

When intrathecal and epidural opioids are administered, pruritus occurs as an unwanted and troublesome side effect. The reported incidence varies between 30% and 100%. The exact mechanisms of neuraxial opioid-induced pruritus remain unclear. Postulated mechanisms include the presence of an "itch center" in the central nervous system, medullary dorsal horn activation, and antagonism of inhibitory transmitters. The treatment of intrathecal opioid-induced pruritus remains a challenge. Many pharmacological therapies, including antihistamines, 5-HT(3)-receptor antagonists, opiate-antagonists, propofol, nonsteroid antiinflammatory drugs, and droperidol, have been studied. In this review, we will summarize pathophysiological and pharmacological advances that will improve understanding and ultimately the management of this troublesome problem.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770663     DOI: 10.1016/s0952-8180(02)00501-9

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  41 in total

1.  Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids.

Authors:  Xian-Yu Liu; Zhong-Chun Liu; Yan-Gang Sun; Michael Ross; Seungil Kim; Feng-Fang Tsai; Qi-Fang Li; Joseph Jeffry; Ji-Young Kim; Horace H Loh; Zhou-Feng Chen
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

2.  Neuraxial morphine after unintentional dural puncture is not associated with reduced postdural puncture headache in obstetric patients.

Authors:  Molly E Brinser; David L Seng; Gordon L Mandell; Jonathan Waters; Patricia L Dalby; Grace Lim
Journal:  J Clin Anesth       Date:  2018-09-11       Impact factor: 9.452

3.  An itch to be scratched.

Authors:  Kush N Patel; Xinzhong Dong
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

4.  Scratching the surface: a role of pain-sensing TRPA1 in itch.

Authors:  Bailong Xiao; Ardem Patapoutian
Journal:  Nat Neurosci       Date:  2011-05       Impact factor: 24.884

5.  Comparison of intrathecal morphine and surgical-site infusion of ropivacaine as adjuncts to intravenous patient-controlled analgesia in living-donor kidney transplant recipients.

Authors:  Joo-Hyun Jun; Gaab-Soo Kim; Jeong Jin Lee; Justin S Ko; Sung Joo Kim; Pil Hyun Jeon
Journal:  Singapore Med J       Date:  2017-08-14       Impact factor: 1.858

Review 6.  The multiple pathways for itch and their interactions with pain.

Authors:  Steve Davidson; Glenn J Giesler
Journal:  Trends Neurosci       Date:  2010-11-05       Impact factor: 13.837

7.  Intrathecal sufentanil (1.5 microg) added to hyperbaric bupivacaine (0.5%) for elective cesarean section provides adequate analgesia without need for pruritus therapy.

Authors:  Yavuz Demiraran; Ismail Ozdemir; Buket Kocaman; Oguz Yucel
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 8.  Pathophysiology and management of opioid-induced pruritus.

Authors:  Arjunan Ganesh; Lynne G Maxwell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability.

Authors:  Ann P Lin; Mei-Chuan Ko
Journal:  ACS Chem Neurosci       Date:  2012-11-06       Impact factor: 4.418

10.  Lornoxicam and ondansetron for the prevention of intrathecal fentanyl-induced pruritus.

Authors:  Nurcin Gulhas; Feray Akgul Erdil; Ozlem Sagir; Ender Gedik; Turkan Togal; Zekine Begec; M Ozcan Ersoy
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.